Block Grant U01IP000090

The National Institute of Child Health and Human Development (NICHD) awarded a $465,966 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Children's Research Institute, a nonprofit pediatric research organization in Washington, D.C. The goal of this 5-year project is to identify factors influencing parental hesitancy towards seasonal respiratory vaccines for children in the post-COVID-19 pandemic era, and to develop a communication...

This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under CFDA 93.865 Child Health and Human Development Extramural Research, will fund a $2,146,691 study to assess the effects of the prenatal respiratory syncytial virus (RSV) prefusion F protein-based (RSVpreF) vaccine on neonatal, lactation, and child health outcomes. The study will leverage electronic health record data and state immunization information systems across...

This $157,744 Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund a research project to develop and pilot an intervention to increase human papillomavirus (HPV) vaccination coverage among rural adolescents in North Carolina. The key objectives are to: 1) define optimal systems for recommending HPV vaccination at age 9 in rural clinics; 2) assess acceptability of age-9 HPV...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268) provides $2,875,590.00 to the Utah Department of Health and Human Services (UDHHS) to strengthen vaccine-preventable disease prevention and response efforts. The 5-year award, effective July 1, 2025 through June 30, 2030, supports UDHHS in establishing and maintaining comprehensive vaccination initiatives targeting diseases such as...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $456,390 to Wake Forest University Health Sciences to conduct research on regulating the immune response to an influenza vaccine in young infants. The key objectives are to understand how varying the duration of antigen delivery impacts the infant B and T cell responses, with the goal of improving the efficacy of influenza vaccines...

The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $1,164,930 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to the RAND Corporation. This 3-year grant, awarded on August 12, 2024, will support research to examine the impact of different school-located vaccination (SLV) models on routine, influenza, and COVID-19 vaccine uptake among school-aged children in Colorado, with a focus on historically excluded populations...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268), supports the South Carolina Department of Public Health (SCDPH) in establishing and maintaining comprehensive vaccination initiatives targeting vaccine-preventable diseases. The $233,610 award, with a period of performance from July 1, 2025, to June 30, 2030, will enable SCDPH to enhance vaccination infrastructure, improve...

The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $2,767,879 Cooperative Agreement under the Immunization Cooperative Agreements (CFDA 93.268) program to the Hawaii Department of Health (HDOH) on July 1, 2025. This 5-year award supports HDOH's efforts to strengthen vaccine-preventable disease prevention and response across Hawaii. Key objectives include enhancing vaccination infrastructure, improving vaccine access, and promoting vaccine...

This Cooperative Agreement award of $3,487,652.00 from the U.S. Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements (CFDA 93.268) program, will support the Indiana Department of Health (IDOH) in strengthening vaccine-preventable disease prevention and response efforts over the five-year period from July 1, 2025 to June 30, 2030. The award will enable IDOH to establish and maintain comprehensive vaccination initiatives targeting diseases such as...

This federal Project Grant award from the Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to implement and evaluate strategies to increase the use of oral antibiotics for children hospitalized with pneumonia. The total award amount is $148,882 and the performance period runs from September 30, 2024 to September 29, 2029. The principal investigator, Dr. Jillian Cotter,...